Literature DB >> 2229138

Assessment of nucleolar organizer regions by automatic image analysis in breast cancer: correlation with DNA content, proliferation rate, receptor status and histopathological grading.

J Rüschoff1, K Neumann, H Contractor, K Plate, C Thomas.   

Abstract

The value of automatic image analysis in the investigation of nucleolus regions (AgNOR) has been examined in tissue sections of 52 malignant and 30 benign breast lesions. Determination of the AgNOR number per cell alone revealed a considerable overlap between benign (range 1.2-3.8) and malignant specimens (range 1.5-16.2). They differed however, highly significantly (P less than 0.001) in their AgNOR sizes. In benign breast disorders the mean AgNOR area per tumour ranged from 0.22 microns2 to 1.07 microns2 (mean 0.39 microns2), whereas in carcinomas AgNOR sites ranged from 0.05 microns2 to 0.22 microns2 (mean 0.09 microns2). AgNOR counts showed a good correlation with histopathological grade (P less than 0.05), aneuploidy (P less than 0.01), proliferation rate as determined by Ki67 immunostaining (P less than 0.01), as well as oestrogen and progesterone receptor content (P less than 0.01). Image analysis proved to be advantageous over AgNOR counting alone as it facilitated the standardization of the AgNOR technique itself and thus, significantly improved its diagnostic specifity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2229138     DOI: 10.1007/bf01612998

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  44 in total

1.  Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level.

Authors:  D Ploton; M Menager; P Jeannesson; G Himber; F Pigeon; J J Adnet
Journal:  Histochem J       Date:  1986-01

2.  Correlation between NOR sizes and numbers in non-Hodgkin's lymphomas.

Authors:  J Crocker; M J Egan
Journal:  J Pathol       Date:  1988-11       Impact factor: 7.996

3.  Nucleolar organizer regions in Spitz nevi and malignant melanomas.

Authors:  A J Howat; D D Giri; D W Cotton; D N Slater
Journal:  Cancer       Date:  1989-02-01       Impact factor: 6.860

4.  Argyrophilic proteins of the nucleolar organizer region in bladder-tumours.

Authors:  E C Ooms; R W Veldhuizen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

5.  The effect of a series of fixatives on the AgNOR technique.

Authors:  P J Smith; N Skilbeck; A Harrison; J Crocker
Journal:  J Pathol       Date:  1988-06       Impact factor: 7.996

Review 6.  At the heart of the nucleolus.

Authors:  G Jordan
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

7.  Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. Workshop, held on 16-17 March, 1979, in the Netherlands Cancer Institute.

Authors: 
Journal:  Eur J Cancer       Date:  1980-11       Impact factor: 9.162

8.  Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry.

Authors:  B Barlogie; W Göhde; D A Johnston; L Smallwood; J Schumann; B Drewinko; E J Freireich
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

9.  Algorithm for a DNA-cytophotometric diagnosis and grading of malignancy.

Authors:  A Böcking; C P Adler; H H Common; M Hilgarth; B Granzen; W Auffermann
Journal:  Anal Quant Cytol       Date:  1984-03

10.  Prognostic significance of DNA measurements in 409 consecutive breast cancer patients.

Authors:  A G Fallenius; G U Auer; J M Carstensen
Journal:  Cancer       Date:  1988-07-15       Impact factor: 6.860

View more
  11 in total

1.  Argyrophilic nucleolar organizer region counts in multiple myeloma: a histopathological study on bone marrow trephine biopsies.

Authors:  A Pich; L Chiusa; F Marmont; N Cappello; R Navone
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Demonstration of silver-stained nucleolar organizer region associated proteins (AgNORs) after wet autoclave pretreatment in breast carcinoma: correlation to tumor stage and long-term survival.

Authors:  D Ofner; B Bier; S Heinrichs; M Berghorn; M Dünser; H A Hagemann; D Langer; W Böcker; K W Schmid
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Nucleolar organizer regions in glottic carcinomas: comparison of DNA cytofluorometry and clinicopathological analysis.

Authors:  Y Yamamoto; T Itoh; T Saka; A Sakakura; H Takahashi
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

4.  Interphase ribosomal RNA cistron staining in chronic myeloid leukaemia.

Authors:  N N Mamaev; G N Salogub; A V Koloskov
Journal:  Clin Mol Pathol       Date:  1995-10

5.  Argyrophilic nucleolar organizer regions in human adrenocortical neoplasms.

Authors:  Y Kida; Y Takano; M Okudaira
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

6.  Nucleolar organizer regions in adenoid cystic carcinoma of the salivary glands.

Authors:  Y Yamamoto; T Itoh; T Saka; H Takahashi
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

7.  Association between AgNORs and Immunohistochemical Expression of ER, PR, HER2/neu, and p53 in Breast Carcinoma.

Authors:  Hussain Gadelkarim Ahmed; Mohammed Ali Al-Adhraei; Ibraheem M Ashankyty
Journal:  Patholog Res Int       Date:  2011-11-01

Review 8.  Measuring proliferation in breast cancer: practicalities and applications.

Authors:  Mark J Beresford; George D Wilson; Andreas Makris
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

9.  Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer.

Authors:  P Dettmar; N Harbeck; C Thomssen; L Pache; P Ziffer; K Fizi; F Jänicke; W Nathrath; M Schmitt; H Graeff; H Höfler
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Enhancement of experimental metastasis by tumor necrosis factor.

Authors:  P Orosz; B Echtenacher; W Falk; J Rüschoff; D Weber; D N Männel
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.